Nexalin Technology (NXL) EPS (Basic) Growth (3y) (2024 - 2026)
Nexalin Technology (NXL) EPS (Basic) Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 19.63% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 3.18% |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 50.64% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -6.23% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 29.56% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 11.31% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 1,801.39% |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 17.98% |
| 10 | Nexalin Technology | 7.01 Mn | 6.00 Mn | 8,897.00 | 2.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.03% |
| Mar 31, 2026 | -0.99% |
| Dec 31, 2025 | -2.12% |
| Sep 30, 2025 | -29.77% |
| Jun 30, 2025 | -3.05% |
| Mar 31, 2025 | -22.90% |
| Dec 31, 2024 | -29.91% |
| Sep 30, 2024 | 18.18% |